Mice with the P361R mutation in the lysosomal ceramidase, Asah1, exhibit a spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME)-like phenotype and may be a valuable tool to evaluate future therapies for SMA-PME. Here, ASAH1 is linked to Progressive myoclonic epilepsy.